cytarabine has been researched along with Parkinson Disease in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andersson, A; Dannaeus, K; Delfani, K; Di Monte, DA; Haegerstrand, A; Häggblad, J; Hill, MP; Isacson, R; Janson Lang, AM; McCormack, AL; Nielsen, E; Palmer, T; Patrone, C; Rönnholm, H; Wikstrom, L; Zachrisson, O; Zhao, M | 1 |
| Becker, S; Depboylu, C; Gerlach, M; Höglinger, GU; Matusch, A; Michel, PP; Oertel, WH; Riederer, P; Tribl, F; Zoriy, M | 1 |
| Conry, JA; Dinndorf, PA; Kapur, S; Mott, SH; Packer, RJ; Pranzatelli, MR; Quinones, RR; Vezina, LG | 1 |
| Kent, S | 1 |
4 other study(ies) available for cytarabine and Parkinson Disease
| Article | Year |
|---|---|
Restorative effects of platelet derived growth factor-BB in rodent models of Parkinson's disease.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Angiogenesis Inducing Agents; Animals; Becaplermin; Cell Proliferation; Cytarabine; Disease Models, Animal; Drug Administration Schedule; Immunosuppressive Agents; Male; Mice; Mice, Inbred C57BL; Motor Activity; Neurotoxins; Oxidopamine; Parkinson Disease; Proto-Oncogene Proteins c-sis; Rats; Rats, Sprague-Dawley; Time Factors | 2011 |
Glia protects neurons against extracellular human neuromelanin.
Topics: Animals; Cell Survival; Cells, Cultured; Coculture Techniques; Cytarabine; Dose-Response Relationship, Drug; Embryo, Mammalian; Humans; Immunosuppressive Agents; Melanins; Mesencephalon; Microtubule-Associated Proteins; Neuroglia; Neurons; Parkinson Disease; Postmortem Changes; Rats; Rats, Wistar; Reactive Oxygen Species; Substantia Nigra; Tyrosine 3-Monooxygenase | 2007 |
Encephalopathy with parkinsonian features in children following bone marrow transplantations and high-dose amphotericin B.
Topics: Adolescent; Amphotericin B; Antineoplastic Agents; Aspergillosis; Bone Marrow Transplantation; Brain Diseases; Child; Cyclophosphamide; Cytarabine; Humans; Leukemia, Myeloid, Acute; Lung Diseases; Male; Methotrexate; Parkinson Disease; Radiation Injuries | 1995 |
Continuous drug delivery methods reflect progress in therapy for chronic diseases.
Topics: Aged; Chronic Disease; Cytarabine; Dosage Forms; Drug Implants; Glaucoma; Humans; Injections, Intravenous; Leukemia; Levodopa; Neoplasms; Parkinson Disease; Pilocarpine; Research | 1977 |